Systemic epidermal nevus with involvement of the oral mucosa due to FGFR3 mutation

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Bygum, Anette ^a   Fagerberg, Christina R ^a   Clemmensen, Ole J ^a   Fiebig, Britta ^b   Hafner, Christian ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; CASE REPORT; EPIDERMIS; FEMALE; GENE MUTATION; HUMAN; MOLECULAR GENETICS; MOSAICISM; MOUTH DISEASE; MOUTH MUCOSA; NEVUS; SCOLIOSIS; GENETICS; MISSENSE MUTATION; PATHOLOGY;

EPIDERMIS; FEMALE; HUMANS; MOSAICISM; MOUTH MUCOSA; MUTATION, MISSENSE; NEVUS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;

EID: 79957798424     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-79     Document Type: Article

References (31)

1. Happle R. The group of epidermal nevus syndromes Part I. Well defined phenotypes. J Am Acad Dermatol 2010, 63:1-22. 10.1016/j.jaad.2010.01.017, 20542174.
2. Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg 2007, 26:221-230. 10.1016/j.sder.2008.03.006, 18395670.
3. Happle R. Mosaicism in human skin. Understanding the patterns and mechanisms. Arch Dermatol 1993, 129:1460-1470. 10.1001/archderm.129.11.1460, 8239703.
4. Happle R, Rogers M. Epidermal nevi. Adv Dermatol 2002, 18:175-201.
5. Hafner C, López-Knowles E, Luis NM, Toll A, Baselga E, Fernández-Casado A, Hernández S, Ribé A, Mentzel T, Stoehr R, et al. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci USA 2007, 104:13450-13454. 10.1073/pnas.0705218104, 1948900, 17673550.
6. Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 2006, 116:2201-2207. 10.1172/JCI28163, 1501112, 16841094.
7. Hurst CD, Zuiverloon TC, Hafner C, Zwarthoff EC, Knowles MA. A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene. BMC Res Notes 2009, 2:66. 10.1186/1756-0500-2-66, 2683860, 19402901.
8. Rogers M, McCrossin I, Commens C. Epidermal nevi and the epidermal nevus syndrome. A review of 131 cases. J Am Acad Dermatol 1989, 20:476-488. 10.1016/S0190-9622(89)70061-X, 2918116.
9. Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X, Chopin D, Thiery JP, Radvanyi F. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet 1999, 23:18-20.
10. Gymnopoulos M, Elsliger MA, Vogt PK. Rare cancer-specific mutations in PIK3CA show gain of function. Proc Natl Acad Sci USA 2007, 104:5569-5574. 10.1073/pnas.0701005104, 1838453, 17376864.
11. Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995, 9:321-328. 10.1038/ng0395-321, 7773297.
12. Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol 1987, 16:899-906. 10.1016/S0190-9622(87)80249-9, 3033033.
13. Hafner C, van Oers JM, Hartmann A, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Vogt T. High Frequency of FGFR3 Mutations in Adenoid Seborrheic Keratoses. J Invest Dermatol 2006, 126:2404-2407. 10.1038/sj.jid.5700422, 16778799.
14. Logié A, Dunois-Lardé C, Rosty C, Levrel O, Blanche M, Ribeiro A, Gasc JM, Jorcano J, Werner S, Sastre-Garau X, et al. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 2005, 14:1153-1160. 10.1093/hmg/ddi127, 15772091.
15. Hafner C, Vogt T. Seborrheic keratosis. J Dtsch Dermatol Ges 2008, 6:664-677. 10.1111/j.1610-0387.2008.06788.x, 18801147.
16. Bernard-Pierrot I, Brams A, Dunois-Lardé C, Caillault A, Diez de Medina SG, Cappellen D, Graff G, Thiery JP, Chopin D, Ricol D, et al. Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b. Carcinogenesis 2006, 27:740-747.
17. Bader AG, Kang S, Vogt PK. Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci USA 2006, 103:1475-1479. 10.1073/pnas.0510857103, 1360603, 16432179.
18. Hafner C, Di Martino E, Pitt E, Stempfl T, Tomlinson D, Hartmann A, Landthaler M, Knowles M, Vogt T. FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes. Exp Cell Res 2010, 316:2008-2016. 10.1016/j.yexcr.2010.04.021, 20420824.
19. Hafner C, Toll A, Fernández-Casado A, Earl J, Marqués M, Acquadro F, Méndez-Pertuz M, Urioste M, Malats N, Burns JE, et al. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci USA 2010, 107:20780-20785. 10.1073/pnas.1008365107, 2996414, 21078999.
20. Haberland-Carrodeguas C, Allen CM, Lovas JG, Hicks J, Flaitz CM, Carlos R, Stal S. Review of linear epidermal nevus with oral mucosal involvement--series of five new cases. Oral Dis 2008, 14:131-137. 10.1111/j.1601-0825.2006.01355.x, 18302672.
21. Collin B, Taylor IB, Wilkie AO, Moss C. Fibroblast growth factor receptor 3 (FGFR3) mutation in a verrucous epidermal naevus associated with mild facial dysmorphism. Br J Dermatol 2007, 156:1353-1356. 10.1111/j.1365-2133.2007.07869.x, 17441958.
22. García-Vargas A, Hafner C, Pérez-Rodríguez AG, Rodriguez-Rojas LX, González-Esqueda P, Stoehr R, Hernández-Torres M, Happle R. An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation. Am J Med Genet A 2008, (146A):2275-2279.
23. Rongioletti F, Rebora A. Epidermal nevus with transitional cell carcinomas of the urinary tract. J Am Acad Dermatol 1991, 25(5 Pt 1):856-858.
24. Rosenthal D, Fretzin DF. Epidermal nevus syndrome: report of association with transitional cell carcinoma of the bladder. Pediatr Dermatol 1986, 3:455-458. 10.1111/j.1525-1470.1986.tb00650.x, 3562359.
25. García de Jalón A, Azúa-Romeo J, Trivez MA, Pascual D, Blas M, Rioja LA. Epidermal naevus syndrome (Solomon's syndrome) associated with bladder cancer in a 20-year-old female. Scand J Urol Nephrol 2004, 38:85-87. 10.1080/00365590310017316, 15204433.
26. Hernández S, Toll A, Baselga E, Ribé A, Azua-Romeo J, Pujol RM, Real FX. Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors. J Invest Dermatol 2007, 127:1664-1666.
27. Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, Bergsagel PL. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 1997, 16:260-264. 10.1038/ng0797-260, 9207791.
28. Ichikawa T, Saiki M, Kaneko M, Saida T. Squamous cell carcinoma arising in a verrucous epidermal nevus. Dermatology 1996, 193:135-138. 10.1159/000246229, 8884151.
29. Hafner C, Klein A, Landthaler M, Vogt T. Clonality of basal cell carcinoma arising in an epidermal nevus. New insights provided by molecular analysis. Dermatology 2009, 218:278-281. 10.1159/000189209, 19122450.
30. Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg 2004, 23:145-157. 10.1016/j.sder.2004.01.008, 15295924.
31. Hyland VJ, Robertson SP, Flanagan S, Savarirayan R, Roscioli T, Masel J, Hayes M, Glass IA. Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia. Am J Med Genet A 2003, 120:157-168.